SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  REGADO BIOSCIENCES INC FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

[December 23, 2013]

REGADO BIOSCIENCES INC FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On December 19, 2013, the Board of Directors (the "Board") of Regado Biosciences, Inc. (the "Company"), based upon the recommendation of the Compensation Committee thereof, approved an amendment to the amended and restated employment agreement between the Company and its Chief Executive Officer, David J. Mazzo, Ph.D. The amendment provides for eligibility for a cash bonus equal to 100% of annual base salary, in lieu of his annual target bonus of 50% of his annual base salary, if certain corporate objectives specified in the amendment are achieved in 2014 or 2015 and certain revisions to the Section 280G cutback provisions in his employment agreement.


The Compensation Committee also approved amendments to the employment agreements for each of the following executive officers: Steven L. Zelenkofske, Christopher Rusconi, Christopher Courts and Alexander R. Gianquinto. These amendments provide for certain revisions to the Section 280G cutback provisions in such officers' employment agreements and, in the case of Mr. Zelenkofske, also provide for reimbursement of reasonable expenses for travel between his place of residence in Pennsylvania and our office in Basking Ridge, New Jersey and for lodging in the Basking Ridge area, of up to $25,000 per year.

The foregoing descriptions of the amendments to the employment agreements for the executive officers are intended to be a summary and are qualified in its entirety by reference to such documents, which are attached as Exhibits 10.1 to 10.5 and are incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits Exhibit 10.1 - First Amendment dated December 23, 2013 to Employment Agreement by and between Regado Biosciences, Inc. and David J. Mazzo, dated May 16, 2013.

Exhibit 10.2 - First Amendment dated December 23, 2013 to Employment Agreement by and between Regado Biosciences, Inc. and Steven L. Zelenkofske, dated May 16, 2013.

Exhibit 10.3 - First Amendment dated December 23, 2013 to Employment Agreement by and between Regado Biosciences, Inc. and Christopher Rusconi, dated May 16, 2013.

Exhibit 10.4 - First Amendment dated December 23, 2013 to Employment Agreement by and between Regado Biosciences, Inc. and Christopher E. Courts, dated May 16, 2013.

Exhibit 10.5 - First Amendment dated December 23, 2013 to Employment Agreement by and between Regado Biosciences, Inc. and Alexander R. Gianquinto, dated May 16, 2013.

--------------------------------------------------------------------------------

[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.